Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ActiMaris is a Swiss medical technology company specializing in the development and manufacture of innovative wound care and skin treatment products. The company's core technology utilizes a combination of active oxygen (singlet oxygen), sea salt, and an alkaline pH to promote healing and eliminate pathogens, including multi-resistant bacteria like MRSA. Their product portfolio includes solutions, gels, and sprays designed for the treatment of chronic wounds, burns, and inflammatory conditions of the skin and mucous membranes. ActiMaris products are widely used in clinical settings for wound bed preparation and infection management without the use of traditional antibiotics or harsh chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ActiMaris.